Breast cancer chemoprevention: little progress in practice?-Reference-Cited by-同舟云学术

Breast cancer chemoprevention: little progress in practice?

Published:2014-03 Issue:9922 Volume:383 Page:1018-1020
ISSN:0140-6736
Container-title:The Lancet
language:en
Short-container-title:The Lancet

Author:

Cameron David A

Publisher

Elsevier BV

Subject

General Medicine

Reference9 articles.

1. Anastrozole for prevention of breast cancer in high-risk postmenopausal women (IBIS-II): an international, double-blind, randomised placebo-controlled trial;Cuzick;Lancet,2013

2. Tamoxifen for prevention of breast cancer: report of the National Surgical Adjuvant Breast and Bowel Project P-1 Study;Fisher;J Natl Cancer Inst,1998

3. Effects of tamoxifen vs raloxifene on the risk of developing invasive breast cancer and other disease outcomes: the NSABP Study of Tamoxifen and Raloxifene (STAR) P-2 trial;Vogel;JAMA,2006

4. Exemestane for breast-cancer prevention in postmenopausal women;Goss;N Engl J Med,2011

5. Modeling of the growth kinetics of occult breast tumors: role in interpretation of studies of prevention and menopausal hormone therapy;Santen;Cancer Epidemiol Biomarkers Prev,2012

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Vielversprechende Langzeitergebnisse zum Einsatz von Anastrozol zur Prävention von Brustkrebs bei postmenopausalen Hochrisikopatientinnen;Strahlentherapie und Onkologie;2020-06-23

2. A Survey among Breast Cancer Specialists on the Low Uptake of Therapeutic Prevention with Tamoxifen or Raloxifene;Cancer Prevention Research;2017-10-23

3. Worry and risk perception of breast cancer in a prevention trial of low dose tamoxifen in midlife postmenopausal hormone users;The Breast;2017-08

4. Barriers to preventive therapy for breast and other major cancers and strategies to improve uptake;ecancermedicalscience;2015-11-24

5. Chemoprevention of cancer: current evidence and future prospects;F1000Research;2015-09-28